M&A Deals in 'Omics Tools, MDx Space Drop 30 Percent in H1 2012 | GenomeWeb

NEW YORK (GenomeWeb News) – Through the first six months of 2012, the number of mergers and acquisitions in the 'omics-related tools and molecular diagnostics markets fell nearly 30 percent compared to a year ago, though a few big deals focused on diagnostics were consummated.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: statistical approach to examine intra-tumor heterogeneity, new genetic condition called otulipenia, and more.

Blood tests looking for biomarker changes could catch mental illnesses earlier, Newsweek reports.

DNA testing offers Korean adoptees a way to find their birth parents that sidesteps bureaucratic red tape, according to the New York Times.

A National Institutes of Health researcher has filed an Equal Employment Opportunity complaint against the agency, the Washington Post reports.